Literature DB >> 9662443

Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav-1, -2, and -3). Cav-1 and Cav-2 genes map to a known tumor suppressor locus (6-A2/7q31).

J A Engelman1, X L Zhang, F Galbiati, M P Lisanti.   

Abstract

Caveolins (Cav-1, -2, and -3) are a gene family of cytoplasmic membrane-anchored scaffolding proteins that: (i) help to sculpt caveolae membranes from the plasma membrane proper; and (ii) participate in the sequestration of inactive signaling molecules. In the adult, caveolin-1 and -2 are co-expressed and are most abundant in type I pneumocytes, endothelia, fibroblastic cells and adipocytes, while the expression of caveolin-3 is restricted to striated muscle cells. However, little is known regarding the genomic organization and developmental expression of the caveolin gene family. Here, using the mouse as a model system, we examine the chromosomal localization, the detailed intron-exon organization, and developmental expression pattern of the caveolin gene family. cDNAs encoding caveolin-1, -2, and -3 were used as probes to isolate murine genomic clones containing these genes. Fluorescence in situ hybridization (FISH) analysis using these genomic clones as probes reveals that all three caveolin genes are localized to murine chromosome 6. Specifically, caveolin-1 and -2 co-localize to chromosomal region 6-A2, while caveolin-3 is located within the chromosomal region 6-E1. Searches of the NCBI Human/Mouse Homology map indicate that murine region 6-A2 corresponds to human chromosome 7q31. As this region (6-A2/7q31) is the site of an as yet unidentified tumor suppressor gene(s), our mapping studies clearly define caveolin-1 and caveolin-2 as candidate genes that may be deleted at these loci. All three caveolin genes show similar intron-exon organization, with the last exon of each gene encoding the bulk of the known caveolin functional domains. The boundary position of the last exon is essentially identical in all three caveolin genes, suggesting that they may have arisen through gene duplication events. Developmentally, all three caveolins were expressed late during mouse embryogenesis as assessed by Northern and Western blot analysis. We examined the localization of the caveolin proteins in sections of day 16 mouse embryos using a well-characterized panel of antibody probes. Caveolin-1 and -2 were most abundantly expressed in the developing lung parenchyma, while caveolin-3 was most abundantly expressed in developing tissues that consist primarily of skeletal muscle cells. As the expression of all three caveolins in the adult is highest in terminally differentiated cell types, this is consistent with the idea that caveolins may be viewed as late markers of differentiation during embryogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9662443     DOI: 10.1016/s0014-5793(98)00619-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  47 in total

Review 1.  Caveolins, liquid-ordered domains, and signal transduction.

Authors:  E J Smart; G A Graf; M A McNiven; W C Sessa; J A Engelman; P E Scherer; T Okamoto; M P Lisanti
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  A role for caveolin-1 in mechanotransduction of fetal type II epithelial cells.

Authors:  Yulian Wang; Benjamin S Maciejewski; Diana Drouillard; Melissa Santos; Michael A Hokenson; Renda L Hawwa; Zheping Huang; Juan Sanchez-Esteban
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-02-19       Impact factor: 5.464

3.  Zebrafish as a novel model system to study the function of caveolae and caveolin-1 in organismal biology.

Authors:  Philippe G Frank; Michael P Lisanti
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

4.  STAT-Related Profiles Are Associated with Patient Response to Targeted Treatments in Locally Advanced SCCHN.

Authors:  Vassiliki Kotoula; Sofia Lambaki; Despina Televantou; Anna Kalogera-Fountzila; Angelos Nikolaou; Konstantinos Markou; Despina Misailidou; Konstantinos N Syrigos; George Fountzilas
Journal:  Transl Oncol       Date:  2011-02-01       Impact factor: 4.243

5.  Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension.

Authors:  Eric D Austin; Lijiang Ma; Charles LeDuc; Erika Berman Rosenzweig; Alain Borczuk; John A Phillips; Teresa Palomero; Pavel Sumazin; Hyunjae R Kim; Megha H Talati; James West; James E Loyd; Wendy K Chung
Journal:  Circ Cardiovasc Genet       Date:  2012-04-02

6.  Lack of association between rs3807989 in cav1 and atrial fibrillation.

Authors:  Guocao Li; Rongfeng Zhang; Lianjun Gao; Shulong Zhang; Yingxue Dong; Xiaomeng Yin; Dong Chang; Yanzong Yang; Yunlong Xia
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 7.  Regulation of intracellular signaling and function by caveolin.

Authors:  Heidi N Fridolfsson; David M Roth; Paul A Insel; Hemal H Patel
Journal:  FASEB J       Date:  2014-05-22       Impact factor: 5.191

8.  Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice.

Authors:  You-Yang Zhao; Yang Liu; Radu-Virgil Stan; Lian Fan; Yusu Gu; Nancy Dalton; Po-Hsien Chu; Kirk Peterson; John Ross; Kenneth R Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

9.  Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade.

Authors:  F Galbiati; D Volonte; J A Engelman; G Watanabe; R Burk; R G Pestell; M P Lisanti
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

10.  Extensive analysis of D7S486 in primary gastric cancer supports TESTIN as a candidate tumor suppressor gene.

Authors:  Haiqing Ma; Desheng Weng; Yibing Chen; Wei Huang; Ke Pan; Hui Wang; Jiancong Sun; Qijing Wang; Zhiwei Zhou; Huiyun Wang; Jianchuan Xia
Journal:  Mol Cancer       Date:  2010-07-13       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.